Cargando…
COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data
BACKGROUND: Great efforts by the scientific community are rapidly expanding the evidence on the clinical interplay between Covid-19 and inflammatory bowel disease (IBD). AIMS: We performed a systematic review of the literature on published Covid-19 cases occurring in patients with IBD. METHODS: PubM...
Autores principales: | Macaluso, Fabio Salvatore, Orlando, Ambrogio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474894/ https://www.ncbi.nlm.nih.gov/pubmed/32928672 http://dx.doi.org/10.1016/j.dld.2020.09.002 |
Ejemplares similares
-
Could Patients With Inflammatory Bowel Disease Treated With Immunomodulators or Biologics Be at Lower Risk for Severe Forms of COVID-19?
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2021) -
Reply to Comment on: “Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease”
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023) -
Head-to-head comparison of biological drugs for inflammatory bowel disease: from randomized controlled trials to real-world experience
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2021) -
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study
por: Macaluso, Fabio Salvatore, et al.
Publicado: (2023) -
The Role of Portal Vein Thrombosis in the Clinical Course of Inflammatory Bowel Diseases: Report on Three Cases and Review of the Literature
por: Sinagra, Emanuele, et al.
Publicado: (2012)